Pleşeru Ancuţa-Maria, Mihailă Romeo Gabriel
Neurology Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, Romania.
Neurology Department, Emergency Clinical County Hospital Sibiu, Romania.
Clujul Med. 2018 Oct;91(4):368-371. doi: 10.15386/cjmed-973. Epub 2018 Oct 30.
Thrombin is a key factor of hemostasis, mediating the conversion of fibrinogen into fibrin. Along with prothrombin, of which thrombin is the active derivative, it has been found locally expressed in the central nervous system. This article aims to describe the role of thrombin in the normal functioning of the central nervous system and stroke.
In this mini-review, the specialized databases Medscape, PubMed, and Web of Science, from the years 2003-2018, were used to find relevant documents by using MeSH terms: "thrombin" and "stroke".
Prothrombin and thrombin influence neural development, protection and regeneration, thrombin being a relatively strong regulating factor of brain function. However, high levels of thrombin are detrimental to neuronal health, and cause atherosclerotic plaque development and instability - a leading cause of cerebral infarction. In stroke, thrombin promotes direct cellular toxicity, vascular disruption, oxidative stress and inflammatory response. There is a direct correlation between thrombin activity in the affected brain hemisphere and the infarction volume. Direct acting thrombin inhibitors, like dabigatran, significantly decrease the risk of ischemic stroke.
Further studies on the correlation between thrombin levels, generation and activity and the risk and recurrence of ischemic cerebral stroke should give new insight on this association, resulting in an optimized practical therapeutic approach.
凝血酶是止血的关键因素,介导纤维蛋白原转化为纤维蛋白。与凝血酶原(凝血酶是其活性衍生物)一起,已发现它们在中枢神经系统中局部表达。本文旨在描述凝血酶在中枢神经系统正常功能和中风中的作用。
在本综述中,使用专业数据库Medscape、PubMed和Web of Science,通过使用医学主题词“凝血酶”和“中风”,检索2003年至2018年期间的相关文献。
凝血酶原和凝血酶影响神经发育、保护和再生,凝血酶是脑功能相对较强的调节因子。然而,高水平的凝血酶对神经元健康有害,并导致动脉粥样硬化斑块的形成和不稳定,这是脑梗死的主要原因。在中风中,凝血酶促进直接细胞毒性、血管破坏、氧化应激和炎症反应。受影响脑半球的凝血酶活性与梗死体积之间存在直接相关性。直接作用的凝血酶抑制剂,如达比加群,可显著降低缺血性中风的风险。
对凝血酶水平、生成和活性与缺血性脑卒风险和复发之间相关性的进一步研究,应能为这种关联提供新的见解,从而产生优化的实际治疗方法。